Skip to main content
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1983 Jul;15(2):87–91. doi: 10.1007/BF00199696

Characterization of tumor-associated lymphocytes in a series of mouse mammary tumor lines with differing biological properties

Angelyn M Rios 1, Fred R Miller 1, Gloria H Heppner 1,
PMCID: PMC11039057  PMID: 6553517

Abstract

Tumor-associated lymphocytes were isolated by isokinetic gradient separation from five related mouse mammary tumor lines with different immunological and growth characteristics. Although considerable variation in recovery rates was seen from experiment to experiment, the five tumor types were found to have reproducible and characteristic patterns of T lymphocyte subpopulations, as detected by cytotoxicity assay using monoclonal antisera to Thy-1, Lyt-1, and Lyt-2 antigens. Tumors of line 168, which are weakly immunogenic at best, had the lowest numbers of recovered ALS+, Thy 1+ lymphocytes (12% and 9%, respectively), in contrast to immunogenic lines (mean 38% and 26%, respectively). Line 68H tumors, which grow after prolonged latency periods and also produce tumor cell variants in vivo, were unique in that the numbers of recovered Lyt 1+ lymphocytes exceeded the numbers of Lyt2+ lymphocytes, whereas these two T cell subpopulations were either equal or Lyt2+ cells predominated in the other faster growing, non-variant-producing tumors. No differences in T lymphocyte distribution were associated with the presence or absence of metastatic behavior. These results indicate that distinctive lymphocyte infiltrates may be characteristic of tumors with distinct biological differences.

Keywords: Biological Difference, Cell Subpopulation, Cell Variant, Lymphocyte Subpopulation, Lymphocyte Infiltrate

References

  • 1.Blazar BA, Heppner GH. In situ lymphoid cells of mouse mammary tumors. I. Development and evaluation of a method for the separation of lymphoid cells from mouse mammary tumors. J Immunol. 1978;120:1876. [PubMed] [Google Scholar]
  • 2.Blazar BE, Heppner GH. In situ lymphoid cell of mouse mammary tumors. II. The characterization of lymphoid cells separated from mouse mammary tumors. J Immunol. 1978;120:1881. [PubMed] [Google Scholar]
  • 3.Blazar BA, Miller FR, Heppner GH. In situ lymphoid cells of mouse mammary tumors. III. In vitro stimulation of tumor cell survival by lymphoid cells separated from mammary tumors. J Immunol. 1978;120:1887. [PubMed] [Google Scholar]
  • 4.Blazar BA, Laing CA, Miller FR, Heppner GH. Activity of lymphoid cells separated from mammary tumors in blastogenesis and Winn assays. J Natl Cancer Inst. 1980;65:405. [PubMed] [Google Scholar]
  • 5.Dexter DL, Kowalski HM, Blazar BA, Fligiel Z, Vogel R, Heppner GH. Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res. 1978;38:3174. [PubMed] [Google Scholar]
  • 6.Hager JC, Miller FR, Heppner GH. The influence of serial transplantation on the immunological-clinical correlates of strain BALB/cfC3H mouse mammary tumors. Cancer Res. 1978;38:2492. [PubMed] [Google Scholar]
  • 7.Hager JC, Fligiel S, Stanley W, Richardson AM, Heppner GH. Characterization of a variant-producing tumor cell line from a heterogeneous strain BALB/cfC3H mouse mammary tumor. Cancer Res. 1981;41:1293. [PubMed] [Google Scholar]
  • 8.Heppner GH, Dexter DL, DeNucci T, Miller FR, Calabresi P. Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mouse mammary tumor. Cancer Res. 1978;38:3758. [PubMed] [Google Scholar]
  • 9.Loveless SE, Munson AE, Heppner GH. Tumoricidal macrophages isolated from murine mammary tumors that differ in biological behavior. Proc Am Assoc Cancer Res. 1982;23:1034. [Google Scholar]
  • 10.Miller BE, Miller FR, Leith J, Heppner GH. Growth interaction in vivo between tumor subpopulations derived from a single mouse mammary tumor. Cancer Res. 1980;40:3977. [PubMed] [Google Scholar]
  • 11.Mule JJ, Forstrom JW, George E, Hellstrom I, Hellstrom KE. Production of T cell lines with inhibitory or stimulatory activity against syngeneic tumors in vivo. A preliminary report. Int J Cancer. 1981;28:611. doi: 10.1002/ijc.2910280513. [DOI] [PubMed] [Google Scholar]
  • 12.Pretlow TG. Estimation of experimental conditions that permit cell separations by velocity sedimentation on isokinetic gradients of Ficoll in tissue culture medium. Anal Biochem. 1971;41:248. doi: 10.1016/0003-2697(71)90207-7. [DOI] [PubMed] [Google Scholar]
  • 13.Stutman O. Humoral thymic factors influencing post thymic cells. Ann NY Acad Sci. 1975;249:89. doi: 10.1111/j.1749-6632.1975.tb29060.x. [DOI] [PubMed] [Google Scholar]
  • 14.Stutman O, Shen FW. Postthymic precursor cells give rise to both Lyt-1 and Lyt-2,3 subsets of T cells. Transplant Proc. 1979;9:907. [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES